Sugi Predict

Sugi Predict / Compounds / SCHEMBL1815751

SCHEMBL1815751

SCHEMBL1815751

CC(C)(C)OC(=O)N1CCC(=O)c2ccc(Br)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABHD6 Q9BV23 1/20 0.42
▸ GPR119 Q8TDV5 2/20 0.39
▸ UCHL1 P09936 1/20 0.39
▸ BUB1 O43683 1/20 0.38
▸ CDK1 P06493 2/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ CCNB2 O95067 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ CCNB3 Q8WWL7 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRG2 P18507 2/20 0.38
▸ GABRB3 P28472 2/20 0.38
▸ GABRA5 P31644 2/20 0.38
▸ GABRA3 P34903 2/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ GABRA6 Q16445 2/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ BACE1 P56817 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29829118 1.00 ABHD6 (0.42) ABHD6GPR119UCHL1BUB1CDK1
SCHEMBL3531912 0.94 BRD4 (0.43) ABHD6GPR119UCHL1BUB1CDK1
SCHEMBL25497928 0.90 ABHD6 (0.44) ABHD6GPR119UCHL1BUB1CDK1
SCHEMBL30058942 0.90 ABHD6 (0.44) ABHD6GPR119UCHL1BUB1CDK1
SCHEMBL22868066 0.86 KDM4E (0.41) GPR119BUB1KDM1ABRD4CHRM4
SCHEMBL31064203 0.85 CHRM4 (0.39) GPR119UCHL1BUB1KDM1ABRD4
SCHEMBL30804525 0.84 NOTUM (0.44) GPR119BUB1GABRA1GABRG2GABRB3
SCHEMBL6647243 0.84 NOTUM (0.44) GPR119BUB1GABRA1GABRG2GABRB3
SCHEMBL6341898 0.84 BRD4 (0.46) ABHD6GPR119UCHL1BUB1CDK1
SCHEMBL595638 0.83 CHRM4 (0.51) ABHD6GPR119UCHL1KDM1ACHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-11-07 — — US disclosed
US-9216972-B2 Tricyclic heterocyclic compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2015-12-22 — — US disclosed
EP-2597089-A1 Tricyclic heterocyclic compounds Bristol-Myers Squibb Company (US) 2013-05-29 — — EP disclosed
EP-2493866-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS Bristol-Myers Squibb Company (US) 2012-09-05 — — EP disclosed
US-20120214767-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY 2012-08-23 — — US disclosed
WO-2011059784-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214767-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS S1PR1, S1PR3, TBXA2R ABHD6 3683/4885GPR119 57/4885UCHL1 4682/4885
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 PRMT5, PRMT6, PRMT1 ABHD6 3245/4885GPR119 3844/4885UCHL1 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.